News of the WeekDRUG SAFETY

Heart Attack Risk Overshadows a Popular Diabetes Therapy

See allHide authors and affiliations

Science  15 Jun 2007:
Vol. 316, Issue 5831, pp. 1550-1551
DOI: 10.1126/science.316.5831.1550

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Two separate analyses have linked the diabetes drug Avandia to heart attacks, prompting congressional hearings, patient anxiety, and demands that the U.S. Food and Drug Administration explain why potentially severe problems with an approved drug have gone undetected until now.